Heardley Moses Murdock, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Leukemia, Myeloid, Acute | 7 | 2024 | 3589 | 0.920 |
Why?
|
Teaching Rounds | 2 | 2021 | 275 | 0.660 |
Why?
|
Hematopoietic Stem Cell Transplantation | 5 | 2024 | 5551 | 0.640 |
Why?
|
Videoconferencing | 1 | 2020 | 197 | 0.610 |
Why?
|
Graft vs Host Disease | 4 | 2024 | 2964 | 0.550 |
Why?
|
Learning | 4 | 2023 | 1719 | 0.500 |
Why?
|
Students, Medical | 3 | 2023 | 1884 | 0.480 |
Why?
|
Clinical Clerkship | 1 | 2019 | 558 | 0.430 |
Why?
|
Graft vs Leukemia Effect | 1 | 2024 | 121 | 0.230 |
Why?
|
Transplantation, Homologous | 5 | 2024 | 4638 | 0.220 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3068 | 0.210 |
Why?
|
Recurrence | 3 | 2024 | 8420 | 0.210 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3187 | 0.200 |
Why?
|
Guanine Nucleotide Exchange Factors | 2 | 2015 | 568 | 0.190 |
Why?
|
Transplantation Conditioning | 3 | 2024 | 1555 | 0.180 |
Why?
|
Pandemics | 1 | 2020 | 8511 | 0.180 |
Why?
|
Myeloid-Lymphoid Leukemia Protein | 1 | 2022 | 302 | 0.170 |
Why?
|
Dioxygenases | 1 | 2021 | 334 | 0.170 |
Why?
|
Health Facilities | 1 | 2023 | 571 | 0.160 |
Why?
|
Goals | 1 | 2023 | 701 | 0.160 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2022 | 680 | 0.150 |
Why?
|
Neoplasm, Residual | 1 | 2022 | 994 | 0.140 |
Why?
|
Sulfonamides | 2 | 2024 | 1963 | 0.140 |
Why?
|
Leukemia | 2 | 2022 | 1500 | 0.140 |
Why?
|
Picornaviridae Infections | 1 | 2017 | 94 | 0.130 |
Why?
|
Internal Medicine | 1 | 2023 | 1032 | 0.130 |
Why?
|
Rhinovirus | 1 | 2017 | 199 | 0.130 |
Why?
|
Cultural Diversity | 1 | 2019 | 352 | 0.130 |
Why?
|
Aminopeptidases | 1 | 2014 | 94 | 0.120 |
Why?
|
Dipeptidyl-Peptidases and Tripeptidyl-Peptidases | 1 | 2014 | 89 | 0.120 |
Why?
|
Myeloablative Agonists | 1 | 2015 | 203 | 0.120 |
Why?
|
Cell Shape | 1 | 2014 | 373 | 0.110 |
Why?
|
Schools, Medical | 1 | 2019 | 874 | 0.110 |
Why?
|
Severe Combined Immunodeficiency | 1 | 2015 | 224 | 0.100 |
Why?
|
Evolution, Molecular | 1 | 2021 | 1882 | 0.100 |
Why?
|
Myelodysplastic Syndromes | 1 | 2022 | 1376 | 0.100 |
Why?
|
Immunologic Deficiency Syndromes | 1 | 2014 | 553 | 0.090 |
Why?
|
Glycolysis | 1 | 2014 | 826 | 0.090 |
Why?
|
Education, Medical, Undergraduate | 1 | 2019 | 1049 | 0.090 |
Why?
|
Adaptive Immunity | 1 | 2014 | 719 | 0.090 |
Why?
|
Hematologic Neoplasms | 1 | 2021 | 1864 | 0.090 |
Why?
|
Serine Endopeptidases | 1 | 2014 | 1017 | 0.080 |
Why?
|
Immunity | 1 | 2014 | 993 | 0.080 |
Why?
|
Busulfan | 2 | 2021 | 248 | 0.080 |
Why?
|
Humans | 19 | 2024 | 752411 | 0.070 |
Why?
|
Vidarabine | 2 | 2021 | 328 | 0.070 |
Why?
|
Killer Cells, Natural | 1 | 2014 | 2174 | 0.060 |
Why?
|
Genomics | 1 | 2021 | 5728 | 0.060 |
Why?
|
DNA-Binding Proteins | 1 | 2021 | 9551 | 0.060 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2021 | 9207 | 0.050 |
Why?
|
Immunity, Innate | 1 | 2014 | 3029 | 0.050 |
Why?
|
Azacitidine | 1 | 2024 | 336 | 0.050 |
Why?
|
Immunosuppressive Agents | 1 | 2015 | 4067 | 0.050 |
Why?
|
Mutation | 4 | 2022 | 29706 | 0.050 |
Why?
|
Physicians | 1 | 2019 | 4551 | 0.050 |
Why?
|
Gene Duplication | 1 | 2022 | 316 | 0.050 |
Why?
|
Skin | 1 | 2014 | 4426 | 0.050 |
Why?
|
Alleles | 2 | 2022 | 6879 | 0.050 |
Why?
|
Students, Premedical | 1 | 2019 | 3 | 0.040 |
Why?
|
Problem Solving | 1 | 2021 | 437 | 0.040 |
Why?
|
Pedigree | 2 | 2017 | 4573 | 0.040 |
Why?
|
Personnel Selection | 1 | 2019 | 191 | 0.040 |
Why?
|
T-Lymphocytes | 1 | 2014 | 10035 | 0.040 |
Why?
|
Genes, Recessive | 1 | 2017 | 626 | 0.030 |
Why?
|
p21-Activated Kinases | 1 | 2014 | 128 | 0.030 |
Why?
|
cdc42 GTP-Binding Protein | 1 | 2014 | 187 | 0.030 |
Why?
|
Interferons | 1 | 2017 | 700 | 0.030 |
Why?
|
Retrospective Studies | 1 | 2022 | 79133 | 0.030 |
Why?
|
Histocompatibility Testing | 1 | 2015 | 687 | 0.030 |
Why?
|
Career Choice | 1 | 2019 | 751 | 0.030 |
Why?
|
Aged | 2 | 2022 | 166585 | 0.030 |
Why?
|
Chemokine CXCL12 | 1 | 2014 | 453 | 0.030 |
Why?
|
Homozygote | 1 | 2017 | 1784 | 0.030 |
Why?
|
RNA | 1 | 2022 | 2700 | 0.030 |
Why?
|
Emotions | 1 | 2023 | 2693 | 0.020 |
Why?
|
Chemotaxis | 1 | 2014 | 593 | 0.020 |
Why?
|
Tacrolimus | 1 | 2015 | 721 | 0.020 |
Why?
|
Repressor Proteins | 1 | 2022 | 2973 | 0.020 |
Why?
|
Siblings | 1 | 2015 | 824 | 0.020 |
Why?
|
Heterozygote | 1 | 2017 | 2785 | 0.020 |
Why?
|
Cell Cycle Proteins | 1 | 2022 | 3435 | 0.020 |
Why?
|
Sequence Alignment | 1 | 2014 | 2175 | 0.020 |
Why?
|
Chromatin | 1 | 2022 | 2916 | 0.020 |
Why?
|
Immunophenotyping | 1 | 2015 | 1861 | 0.020 |
Why?
|
Cytoskeleton | 1 | 2014 | 1168 | 0.020 |
Why?
|
Proto-Oncogene Proteins | 1 | 2022 | 4474 | 0.020 |
Why?
|
Lysosomes | 1 | 2014 | 911 | 0.020 |
Why?
|
Cattle | 1 | 2014 | 3848 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2017 | 4110 | 0.020 |
Why?
|
Epigenesis, Genetic | 1 | 2022 | 3706 | 0.020 |
Why?
|
Host-Pathogen Interactions | 1 | 2017 | 1439 | 0.020 |
Why?
|
Methotrexate | 1 | 2015 | 1703 | 0.020 |
Why?
|
Cell Adhesion | 1 | 2014 | 3088 | 0.020 |
Why?
|
Immunologic Memory | 1 | 2014 | 1324 | 0.020 |
Why?
|
Female | 7 | 2022 | 386085 | 0.020 |
Why?
|
Survival Rate | 1 | 2021 | 12745 | 0.020 |
Why?
|
Fibroblasts | 1 | 2017 | 4058 | 0.020 |
Why?
|
Child, Preschool | 2 | 2021 | 41660 | 0.020 |
Why?
|
Cytokines | 1 | 2021 | 7235 | 0.020 |
Why?
|
Chronic Disease | 1 | 2021 | 9162 | 0.020 |
Why?
|
Collagen | 1 | 2014 | 2627 | 0.020 |
Why?
|
Base Sequence | 1 | 2017 | 12432 | 0.020 |
Why?
|
Cell Nucleus | 1 | 2014 | 2905 | 0.020 |
Why?
|
Signal Transduction | 2 | 2022 | 23234 | 0.020 |
Why?
|
Disease Progression | 1 | 2022 | 13405 | 0.020 |
Why?
|
Adult | 4 | 2021 | 216927 | 0.020 |
Why?
|
Male | 6 | 2021 | 354908 | 0.020 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2021 | 8422 | 0.020 |
Why?
|
Antiviral Agents | 1 | 2017 | 3031 | 0.020 |
Why?
|
Models, Molecular | 1 | 2014 | 5385 | 0.010 |
Why?
|
Graft Survival | 1 | 2015 | 3626 | 0.010 |
Why?
|
Gene Expression | 1 | 2017 | 7580 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2014 | 13410 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2014 | 17591 | 0.010 |
Why?
|
Pilot Projects | 1 | 2015 | 8443 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2017 | 18915 | 0.010 |
Why?
|
Child | 2 | 2021 | 79004 | 0.010 |
Why?
|
Adolescent | 2 | 2021 | 86766 | 0.010 |
Why?
|
Prognosis | 1 | 2021 | 29337 | 0.010 |
Why?
|
Time Factors | 1 | 2021 | 39846 | 0.010 |
Why?
|
Infant | 1 | 2021 | 35675 | 0.010 |
Why?
|
Apoptosis | 1 | 2014 | 9429 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2019 | 25539 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2014 | 21717 | 0.010 |
Why?
|
Young Adult | 1 | 2021 | 57632 | 0.010 |
Why?
|
Animals | 2 | 2014 | 166811 | 0.010 |
Why?
|
United States | 1 | 2019 | 71438 | 0.010 |
Why?
|
Mice | 1 | 2014 | 80550 | 0.000 |
Why?
|
Middle Aged | 1 | 2021 | 217039 | 0.000 |
Why?
|